CClinicalTrials.gg
Status unknownNCT03589872Updated Jan 15, 2019

The Fine Motor Dexterity Under Dual Task in Parkinson's Disease

An observational study in Fine Motor Skill Dysfunction and Parkinson Disease, sponsored by T.C. ORDU ÜNİVERSİTESİ. Status unknown at 1 site in Turkey. Open to participants aged 50 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-15.

Sponsored by T.C. ORDU ÜNİVERSİTESİ · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
53
Ages
50 Years to 90 Years
Sex
All
01

Study summary

This study was planned to investigate the contribution of dual task interference on dexterity related ADL disability in patients with Parkinson's disease. We hypothesised that the dual task interference is an indicator of dexterity related ADL difficulties.

Read the detailed description

We planned this study as a cross sectional trial. 53 patients with Parkinson's disease will be evaluated under 2 different task by nine hole peg test. Besides this assessment the cardinal symptoms (bradykinesia, tremor, rigidity) will be evaluated to determine their contribution on the ADL performance.

02

Conditions studied

  • Fine Motor Skill Dysfunction
  • Parkinson Disease

Browse trials for

Keywords

  • hand function, dual task, Parkinson disease, activities of daily living
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,081 are open to participants now.

This study's planned enrollment of 53 is below the median of 96 across 1,056 observational studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

T.C. ORDU ÜNİVERSİTESİ is the lead sponsor of 87 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

community sample:community-dwelling patients with Parkinson disease.

Inclusion criteria

  • Diagnosis of idiopathic Parkinson's disease according to the criteria of the United Kingdom brain Bank by neurologist
  • Age 50-90 range
  • having sufficient cognitive status according to the Mini Mental Status Evaluation (24 or above from the Mini Mental Test)

Exclusion criteria

Exclusion Criteria:

  • Having orthopedic and neurological disorders affecting hand function,
  • Having sensory problems,
  • Having Diabetus mellitus
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
53 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Group

    patients with parkinson disease

    Diagnostic Test: Fine motor dexterity test, nine hole peg test

Interventions

  • Diagnostic testFine motor dexterity test, nine hole peg test

    The nine hole peg test will be performed under two different task (1)single task, (2)adding a cognitive task

06

What researchers measure

Primary outcomes

  1. Nine hole peg test

    The Nine-Hole Peg Test is used to measure finger dexterity in patients with various neurological diagnoses. The patient must pick up the pegs from the holes and replace them back as fast as possible. The Nine Hole Peg Test should be conducted with the dominant arm first, then nondominant hand. The time will be recorded in second to complete the test. The test will be performed under three task; 1. single task: Only nine-hole peg test 2. adding a cognitive task: Nine-hole peg test will be performed with a concurrent cognitive task. The cognitive task is a serial 7 subtraction from numbers changed between 290 and 310 during the performing nine-hole peg test. The time will be recorded.

    Time frame: 5 minutes

  2. ADL-related dexterity Questionnaire 24 (DextQ-24)

    Dexterity-related ADL difficulties were measured by the ADL-related dexterity Questionnaire 24 (DextQ-24), including 24 question dealing with bimanual and unimanual activities, which is a reliable and valid disease specific questionnaire to evaluate dexterity in patients with PD. Each question is scored between 1 (no problems) and 4 (need aid to perform task) by the patient's experience. Total score ranged from 24 points to 96 points.

    Time frame: 10 minutes

Secondary outcomes

  1. Modified Hoehn and Yahr Scale

    Disease progression will be assessed with modified Hoehn and Yahr Scale. The original scale included stages 1 through 5. Since then, stage 0 has been added, and stages 1.5 and 2.5 have been proposed. This modified scale allocates stages from 0 to 5 to indicate the relative level of disability. Stage 0: No signs of disease. Stage 1: Unilateral symptoms only. Stage 1.5: Unilateral and axial involvement. Stage 2: Bilateral symptoms. No impairment of balance. Stage 2.5: Mild bilateral disease with recovery on pull test. Stage 3: Balance impairment. Mild to moderate disease. Physically independent. Stage 4: Severe disability, but still able to walk or stand unassisted. Stage 5: Needing a wheelchair or bedridden unless assisted.

    Time frame: 2 minutes

  2. Unified Parkinson's Disease Rating Scale (UPDRS) - Section of Activities of Daily Living (ADL)

    The UPDRS- ADL section evaluates the impact of Parkinson disease on ADL according to patient's perspective. The ADL section consists of 13 items for gathering information on the patient's own perception of functional impairment due to PD. Each item scores between 0-4. 0 means normal and 4 means severe impairment. The total score change between 0-52. High scores indicate severe impairment.

    Time frame: 10 minutes

  3. Unified Parkinson's Disease Rating Scale (UPDRS) - Motor Section

    Motor section of UPDRS determines the impairment due to the Parkinson's disease. Rigidity, bradykinesia and tremor items which are relating with upper extremity function will be assessed. Each item scores between 0-4. 0 means normal and 4 means severe impairment. The total scores of rigidity, bradykinesia, and tremor, respectively range between 0-8, 0-24 and 0-16.

    Time frame: 10 minutes

07

Study locations

1 site
  • Sevim ACARÖZ CANDAN
    Ordu, Altinordu 52100, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03589872
Lead sponsor
T.C. ORDU ÜNİVERSİTESİ
Responsible party
Sevim ACARÖZ CANDAN (Head of Department fo Physiotherapy and Rehabilitation, T.C. ORDU ÜNİVERSİTESİ) — Principal investigator
First posted
Jul 18, 2018
Start date
May 8, 2018
Primary completion
Dec 15, 2018
Completion
Jan 15, 2019 (estimated)
Last update
Jan 15, 2019

Study contacts

SEVİM ACARÖZ CANDAN
principal investigator · Ordu University, Department of Physiotherapy and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion